Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative analgesics for improving inferior alveolar nerve block success in mandibular molars with acute irreversible pulpitis
PACTR202608876687649Completed
- Sponsor
- Misr International University
- Start
- Nov 2024
- Modality
- Small Molecules, Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised trial of diclofenac, trypsin + chymotrypsin and Placebo-COD Research Private Ltd in irreversible pulpitis (4 arms), sponsored by Misr International University. Primary endpoint: Success of inferior alveolar nerve block anesthesia. Started Nov 2024; status: completed.
02
Drugs
diclofenactrypsin + chymotrypsinPlacebo-COD Research Private Ltd
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on PACTR202608876687649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202608876687649.